🎯 check KD025 (Belumosudil) product page
KD025 (Belumosudil) is a potent, selective ATP-competitive ROCK2 inhibitor. It affects TGF-β/SMAD and IL-17/STAT3 signaling by competitively binding to the kinase active site, effectively inhibiting fibrosis, epithelial-mesenchymal transition, and pro-inflammatory cytokine production.